ANVISA RDCRDC 743/2022
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
RDC 743/2022 is ANVISA Collegiate Board Resolution 743/2022. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).
- Instrument
- RDC
- Full name
- Resolução da Diretoria Colegiada
- Category
- Registration
- Source publication
- Portuguese
- Readable HTML
- 1 language version
- Published
- August 17, 2022
- Effective
- September 1, 2022
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
RDC 743/2022 — risk classifications and decision-period annexes
Complete ANVISA Legis native HTML expression, including every operative paragraph and native table row/cell/span in source order. The served page declares UTF-8 but appends a Latin1-encoded nonoperative editorial disclaimer; its three replacement characters are preserved as publisher artifacts, not silently repaired. Operative legal text is intact. The controlling publication is the federal DOU; scope and later currentness require separate verification.
A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.